Omega Healthcare Investors (NYSE:OHI) Issues FY24 Earnings Guidance

Omega Healthcare Investors (NYSE:OHI) issued an update on its FY24 earnings guidance on Thursday morning. The company provided earnings per share (EPS) guidance of $2.70-2.80 for the period, compared to the consensus estimate of $2.71.

Omega Healthcare Investors Price Performance

Shares of Omega Healthcare Investors stock traded up $0.07 during trading on Friday, hitting $31.34. The stock had a trading volume of 2,470,937 shares, compared to its average volume of 1,414,371. The firm has a market cap of $7.74 billion, a price-to-earnings ratio of 28.23, a P/E/G ratio of 10.26 and a beta of 0.92. Omega Healthcare Investors has a 12 month low of $27.53 and a 12 month high of $34.77. The business’s 50-day moving average is $30.98 and its 200 day moving average is $30.97. The company has a current ratio of 6.76, a quick ratio of 6.76 and a debt-to-equity ratio of 1.35.

Omega Healthcare Investors Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, May 15th. Stockholders of record on Tuesday, April 30th will be given a dividend of $0.67 per share. The ex-dividend date of this dividend is Monday, April 29th. This represents a $2.68 dividend on an annualized basis and a dividend yield of 8.55%. Omega Healthcare Investors’s dividend payout ratio (DPR) is presently 241.44%.

Analyst Ratings Changes

OHI has been the topic of several research analyst reports. Deutsche Bank Aktiengesellschaft assumed coverage on shares of Omega Healthcare Investors in a research report on Tuesday, January 30th. They issued a buy rating and a $36.00 price objective on the stock. Wells Fargo & Company raised shares of Omega Healthcare Investors from an equal weight rating to an overweight rating and increased their price target for the stock from $31.00 to $35.00 in a report on Monday, February 26th. Truist Financial lifted their price objective on shares of Omega Healthcare Investors from $31.00 to $32.00 and gave the stock a hold rating in a report on Tuesday, April 2nd. Bank of America cut Omega Healthcare Investors from a buy rating to a neutral rating and reduced their target price for the company from $33.00 to $31.00 in a research note on Tuesday, January 16th. Finally, Citigroup upgraded Omega Healthcare Investors from a neutral rating to a buy rating and upped their price objective for the stock from $32.00 to $35.00 in a report on Friday, March 22nd. Seven research analysts have rated the stock with a hold rating and six have issued a buy rating to the stock. According to data from MarketBeat.com, Omega Healthcare Investors currently has an average rating of Hold and a consensus target price of $33.63.

Omega Healthcare Investors Company Profile

Omega is a REIT that invests in the long-term healthcare industry, primarily in skilled nursing and assisted living facilities. Its portfolio of assets is operated by a diverse group of healthcare companies, predominantly in a triple-net lease structure. The assets span all regions within the U.S., as well as in the U.K.